, /PRNewswire/ — National Press Club President Mark Schoeff Jr. today issued the following statement on…
Blog
Alley Cat Allies Continues to Protect the Cats of the Paseo del Morro and Collaborates with Puerto Rico Leaders
Along with Save A Gato, Alley Cat Allies is taking lifesaving action to prevent the lethal…
Mazda Announces New Zinc Green Color
Zinc Green makes its debut on Mazda MX-5 Miata in Japan /PRNewswire/ — Mazda has a…
LATINA CREATOR AND ENTREPRENEUR LAURA TERMINI WINS TWO TELLY AWARDS AND ANNOUNCES NEW SEASON OF "CHICANOL PODCAST"
/PRNewswire/ –Acclaimed content creator, actress, and founder of the multiplatform brand ChicanolLaura Termini, has been honored…
2G Energy Secures Largest Order in Company History, Accelerating North American Data Center Expansion
/PRNewswire/ –2G Energy North America, a leading provider of decentralized energy solutions and combined heat and…
Medicare Fraud Prevention Week Helps People Spot and Stop Scams
/PRNewswire/ — The fifth annual Medicare Fraud PreventionWeek begins Monday, June 1 with the message that…
U.S. Virgin Islands Announces St. John Celebration 2026: History and Collaboration with a Musical Mix
/PRNewswire/ –The U.S. Virgin Islands Department of Tourism, in partnership with the Division of Festivals, is…
Johnson & Johnson’s Phase 3 prostate cancer study shows ERLEADA® (apalutamide) before and after surgery significantly reduces risk of metastasis or death, breaking a decades-long treatment paradigm
Patients were nine times more likely to have little to no cancer remaining in the prostate…